MENU
Logo Made in Germany BIO 2017

Anavex Life Sciences Expands with Promising Alzheimer Treatment to Bavaria

The New York-based Anavex Life Sciences Corp. (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing drug candidates to treat Alzheimer’s disease, other central nervous system diseases, pain and various types of cancer expanded to Martinsried (Munich, Bavaria) in December 2016.

www.anavex.com

Exhibitor: Bavarian U.S. Offices for Economic Development, LLC East Coast Division

Your personal organizer

Your personal organizer

Print list  |  Save as PDF
Xell AG
Booth number: